1. Pawankar, R., et al., World Allergy Organisation (WAO): White book on allergy. 2011, World Allergy Organisation: Wisconsin.
2. Fiocchi, A., et al., World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow’s Milk Allergy (DRACMA) Guidelines. Pediatr Allergy Immunol, 2010. 21 Suppl 21: p. 1-125.
3. Koletzko, S., et al., Diagnostic approach and management of cow’s-milk protein allergy in infants and children: ESPGHAN GI Committee practical guidelines. J Pediatr Gastroenterol Nutr, 2012. 55(2): p. 221-9.
4. Dharmage, S.C., et al., Atopic dermatitis and the atopic march revisited. Allergy, 2014. 69(1): p. 17-27.
5. Fiocchi, A. et al. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow’s Milk Allergy (DRACMA) Guidelines. Pediatr Allergy Immunol 21 Suppl 21, 1-125, doi:10.1111/j.1399-3038.2010.01068.x (2010).
6. Rona, R. J. et al. The prevalence of food allergy: a meta-analysis. J Allergy Clin Immunol 120, 638-646,doi:10.1016/j.jaci.2007.05.026 (2007).
7. Prescott, S. L. et al. A global survey of changing patterns of food allergy burden in children. World Allergy Organ J 6, 21, doi: 10.1186/1939-4551-6-21 (2013).
8. Schoemaker, A. A. et al. Incidence and natural history of challenge-proven cow’s milk allergy in European children--EuroPrevall birth cohort. Allergy 70, 963-972, doi:10.1111/all.12630 (2015).
9. Akdis, C. Global atlas of allergy. (European Academy of Allergy and Clinical Immunology, 2014), 2014.
10. EAACI. Advocacy manifesto, tackling the allergy crisis in europe-concerted policy action needed, 2015).
11. Kjellman N. Allergy, 1998:53:67-71.
12. Bunekreef B, et al. Pediatr Allergy Immunol, 2002; 13 (15):55-60.
13. Stenius F, et al. J Allergy Clin Immunol, 2011; 128(6):1335-9.
14. Koplin JJ, et al. Int J Environ Res Public Health, 2013; 10(11): 5364–77.
15. Kulig M, et al. Clin Exp Allergy, 1998 Nov; 28(11):1397-403.
16. Kim J, et al. Pediatr Allergy Immunol, 2011 Nov; 22(7):715-9.
17. Lao-Araya M, et al. Pediatr Int, 2012 Apr; 54(2):238-43.
18. Pyrhonen K, et al. Pediatr Allergy Immunol, 2011 Feb; 22(1 Pt 2):e124-32.
19. Lack G, et al. N Engl J Med, 2003; 348:977-985.
20. Neu J, et al. Clin Perinatol, 2011; 38(2):321–31.
21. Fariba A, et al. Pediatr Allergy Immunol, 2017; 28(5):430-7.
22. Kish et al. 2013.
23. Mitsuoka, T. 2014. Establishment of intestinal bacteriology. Biosci Microbiota Food Health 33, 99-116.
24. Roger LC et al, Microbiology, 2010, 156(11):3329-41.
25. Chua, M. C. et al.. J Pediatr Gastroenterol Nutr, (2017).
26. Azad M, et al. Clin Exp Allergy 2015;45:632–43.
27. Kirjavainen P, et al. Gut 2002;51:51–5.
28. Roger LC et al, Microbiology, 2010, 156(11):3329-41.
29. Scholtens PA et al., J Nutr, 2008; 138:1141-7.
30. Mitsuoka, T. Establishment of intestinal bacteriology. Biosci Microbiota Food Health 33, 99-116.
31. Thompson-Chagoyan OC et al, Pediatr Allergy Immonol, 2010; 21(2):394-400.
32. Candy et al. Clin Trans Allergy. 2017; 7(1):10.
33. West, C. E. et al. The gut microbiota and inflammatory noncommunicable diseases: Associations and potentials for gut microbiota therapies. J Allergy Clin Immunol 135, 3-13; quiz 14, doi:10.1016/j.jaci.2014.11.012 (2015).
34. Vighi, G., Marcucci, F., Sensi, L., Di Cara, G. & Frati, F. Allergy and the gastrointestinal system. Clin Exp Immunol 153 Suppl 1, 3-6, doi:10.1111/j.1365-2249.2008.03713.x (2008).
35. Berin, M. C. & Sampson, H. A. Mucosal immunology of food allergy. Curr Biol 23, R389-400, doi:10.1016/j.cub.2013.02.043 (2013).
36. Maynard, C. L., Elson, C. O., Hatton, R. D. & Weaver, C. T. Reciprocal interactions of the intestinal microbiota and immune system. Nature 489, 231-241, doi: 10.1038/nature11551 (2012).
37. Andrew et al. John Wiley & Sons Ltd, Immunology, 142, 24–31 (2013).
38. Helander, H. F. & Fandriks, L. Surface area of the digestive tract – revisited. Scand J Gastroenterol 49, 681-689, doi:10.3109/00365521.2014.898326 (2014).
39. Muraro, A., et al., EAACI food allergy and anaphylaxis guidelines. Primary prevention of food allergy. Allergy, 2014. 69(5): p. 590-601.
40. Vandenplas, Y., et al., Should partial hydrolysates be used as starter infant formula? A working group consensus. Journal of Pediatric Gastroenterology and Nutrition, 2016. 62(1): p. 22-35.
41. Vandenplas, Y., et al., Hydrolyzed formulas for allergy prevention. J Pediatr Gastroenterol Nutr, 2014. 58(5): p. 549-52.
42. Greer, F.R., et al., Effects of early nutritional interventions on the development of atopic disease in infants and children: the role of maternal dietary restriction, breastfeeding, timing of introduction of complementary foods, and hydrolyzed formulas. Pediatrics, 2008. 121(1): p. 183-91.
43. Boyce, J.A., et al., Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report. J Allergy Clin Immunol, 2010. 126(6): p. 1105-18.
44. Walker A. J Pediatr, 2010; 156:S3-S7.
45. Michaelsen, KF. Gesundheitswesen, 2008; 70(Suppl1):S20-21, doi: 10.1055/s-2008-1042417.
46. JeurinkPV, et al. CritRev Food Sci Nutr, 2018 DOI:10.1080/10408398.2017.1405907.
47. Walker WA, et al. Pediatr Res, 2015; 77(1–2):220–8.
48. Bergmann H, et al. British J Nutr, 2014; 112:1119–28.
49. Hunt KM, et al. PLoSOne 6, e21313, doi:10.1371/journal.pone.0021313 (2011).
50. Anagnostou, K. et al. Active management of food allergy: an emerging concept. Arch Dis Child 100, 386- 390, doi: 10.1136/archdischild-2014-306278 (2015).
51. Cuello-Garcia, C.A., et al., World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Prebiotics. World Allergy Organ J, 2016. 9: p. 10.
52. Fiocchi, A., et al., World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Probiotics. World Allergy Organ J, 2015. 8(1): p. 4.
53. Boyle R et al. Allergy, 2016; 71:701–710.
54. Van Esch B. Tox Lett, 2013; 220:95-102.
55. Van Esch B. PAI, 2010; 21:e780-e786.
56. Van Esch B. PAI, 2011:22; 820-826.
57. Van Esch B. PhamaNutrition, 2017:5; 1-7.
58. Billeaud et al. Eur J Clin Nutr. 1990 Aug; 44(8):577-83. 7.
59. Tolia et al. JPGN. 1992 Oct; 15(3):297-301.
60. Mihatsch et al. Acta Paediatr. 2001 Feb; 90(2):196-8.
61. Chin Chua M, et al. JPGN, 2017; 65:102–106.
62. Van der Aa LB, et al. Clin Exp Allergy, 2010; 40:795–804.
63. Van der Aa LB, et al. Allergy, 2011; 66:170-7.
64. De Kivit, et al. J Leukoc Biol, 2017 Jul; 102(1):105-15.
65. Kim J, et al. Pediatr Allergy Immunol, 2011 Nov; 22(7):715.
66. Gibson et al., Nature Reviews Gastroenterology & Hepatology 2017; 75.
67. World Health Organization. Food and Agriculture Organization of the United Nations. Probiotics in food. Health and nutritional properties and guidelines for evaluation. FAO food and nutrition paper 85. 2006
68. Hill C, et al. Nat Rev Gastroenterol Hepatol. 2014 Aug;11(8):506-14.
69. Shamir R, et al. Gut Health in Early Life: Significance of the Gut Microbiota and Nutrition for Development and Future Health. 2015; John Wiley and Son.
70. Kearney S, et al. Microb Biotechnol. 2018 Jan; 11(1): 141–144.
71. Kunz, C., et al., Oligosaccharides in human milk: structural, functional, and metabolic aspects. Annu Rev Nutr, 2000. 20: p. 699-722.
72. Stahl et al 1994.Analyt. Biochem. 223/;218-226.
73. Boehm et al 2006..Acta Paediatr 2005; 94: 18-21.
74. Hunt, K.M., et al., Characterization of the diversity and temporal stability of bacterial communities in human milk. PLoS One, 2011. 6(6): p. e21313.
75. Bergmann H, Rodriguez JM, SalminenS and SzajewskaH (2014). Probiotics in human milk and probiotic supplementation in infant nutrition: a workshop report. Br J Nutr, 112:1119-1128.
76. Wind, R.B.A., K; Garthoff, J, , Safety assessment of Bifidobacterium breve M-16V. Fact file : Internal Nutricia Research document, 2017.
77. Moro, G. et al. Dosage-related bifidogenic effects of galacto-and fructooligosaccharidesin formula-fed term infants. J Pediatr Gastroenterol Nutr34, 291-295 (2002).
78. Shamir R, et al. Wiley 2015 Milton, Brisbane, Australia, ed 1
79. Moro G, et al. J Pediatr Gastroenterol Nutr, 2002;34:291-5.
80. Cuello-Garcia et al. World Allergy Organization Journal (2016) 9:10.
81. Moro, G., Arslanoglu, S. & Boehm, G. Reducing the burden of atopic dermatitis--authors' response. Arch Dis Child 92, 655-656 (2007).
82. Arslanoglu, S. et al. Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. J Nutr 138, 1091-1095 (2008).
83. Arslanoglu, S. et al. Early neutral prebiotic oligosaccharide supplementation reduces the incidence of some allergic manifestations in the first 5 years of life. J Biol Regul Homeost Agents 26, 49-59 (2012).
84. Moro G. et al. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch Dis Child 2007; 91:814–819
85. Martin R, et al. Appl Environ Microbiol, 2009; 75(4):965–9.
86. Jost T, et al. Br J Nutr, 2013;110:1253–62.
87. Nutricia, data on file.
88. Van der Aa LB, et al. Clin Exp Allergy, 40:795–804.
89. Schouten B, et al. J Nutr, 2009; 139: 1398-403.
90. Stenius F, et al. J Allergy Clin Immunol, 2011; 128(6):1335-9.
91. Koplin JJ, et al. Int J Environ Res Public Health, 2013; 10(11): 5364–77.
92. Kulig M, et al. Clin Exp Allergy, 1998 Nov; 28(11):1397-403.
93. van der Aa, L. B. et al. Effect of a new synbioticmixture on atopic dermatitis in infants: a randomized-controlled trial. ClinExpAllergy 40, 795-804.
94. Akiyama, K. et al. Atopic asthma caused by Candida albicansacid protease: case reports. Allergy 49, 778-781 (1994).
95. Taniuchi, S. e. a. Administration of Bifidobacterium to Infants with Atopic Dermatitis: Changes in FecalMicroflora and Clinical Symptoms. The Journal of Applied Research 5, 387-393 (2005).
96. Braegger C, Chmielewska A, Decsi T, et al (2011). Supplementation of infant formula with probiotics and/or prebiotics: a systematic review and comment by the ESPGHAN committee on nutrition. J Pediatr Gastroenterol Nutr.; 52:238-50.
97. Gibson, G. R. & Roberfroid, M. B. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 125, 1401-1412 (1995).
98. Oozeer, R. et al. Intestinal microbiology in early life: specific prebiotics can have similar functionalities as human-milk oligosaccharides. Am J Clin Nutr 98, 561S-571S, doi:10.3945/ajcn.112.038893 (2013).
99. Newburg, D. S. Oligosaccharides in human milk and bacterial colonization. J Pediatr Gastroenterol Nutr 30 Suppl 2, S8-17 (2000).
100. Kunz, C., Rodriguez-Palmero, M., Koletzko, B. & Jensen, R. Nutritional and biochemical properties of human milk, Part I: General aspects, proteins, and carbohydrates. Clin Perinatol 26, 307-333 (1999).
101. Kunz, C., Rudloff, S., Baier, W., Klein, N. & Strobel, S. Oligosaccharides in human milk: structural, functional, and metabolic aspects. Annu Rev Nutr 20, 699-722, doi:10.1146/annurev.nutr.20.1.699 (2000).
102. Lewis ZT and Mills DA. Nestle Nutr Inst Workshop Ser, 2017;88:149-59.
103. American Academy of Pediatrics. Committee on Nutrition. Hypoallergenic infant formulas. Pediatrics106, 346-349 (2000).
104. Hougee, S. et al. Oral treatment with probiotics reduces allergic symptoms in ovalbumin-sensitized mice: a bacterial strain comparative study. IntArch Allergy Immunol 151, 107-117, doi: 10.1159/000236000 (2010).
105. Schouten et al. 2009;
106. Inoue Y. et al. Biol. Pharm. Bull. 32(4) 760—763 (2009) Suppressive Effects of Bifidobacterium breve Strain M-16V on T-Helper Type 2 Immune Responses in a Murine Mode
107. Iwabuchi et al. 2009.
108. Safely administered in extremely premature infants, Akiyama et al. 1994;1996; Yamada et al. 2002;
109. Eur J Nutr (2016) 55:1141–1151.
110. The Journal of Applied Research. Vol. 5, No. 2, 2005.
111. 3. Boyle R, et al. Allergy, 2016; 71:701–10.
112. Boyle, et al. Clin Transl Allergy, 2015, 5(Suppl 3):P30. http://www.ctajournal.com/content/5/S3/P30.
113. Tang M. et al, EAACI, 2017.
114. Gouw, et al. Manuscript submitted. Presented at EAACI-PAAM, 2017, London.
115. Van Esch B. PAI, 2011:22; 820-
116. Van Esch B. PhamaNutrition, 2017:5; 1-7.
117. Meulenbroek, L. PAI, 2013; 24; 656-64.
118. Kostadinova, A. Frontiers Immunol, 2017:6; article 673.
119. Meulenbroek, L.A., et al., Oral treatment with beta-lactoglobulin peptides prevents clinical symptoms in a mouse model for cow’s milk allergy. Pediatr Allergy Immunol, 2013. 24(7): p. 656-64.
120. Kostadinova, A.I., et al., A Specific Mixture of Fructo-Oligosaccharides and Bifidobacterium breve M-16V Facilitates Partial Non-Responsiveness to Whey Protein in Mice Orally Exposed to beta-Lactoglobulin-Derived Peptides. Front Immunol, 2016. 7: p. 673.